دورية أكاديمية
أعرض في EDS

Systematic Review of WHO Grade 4 Astrocytoma in the Cerebellopontine Angle: The Impact of Anatomic Corridor on Treatment Options and Outcomes.

التفاصيل البيبلوغرافية
العنوان: Systematic Review of WHO Grade 4 Astrocytoma in the Cerebellopontine Angle: The Impact of Anatomic Corridor on Treatment Options and Outcomes.
المؤلفون: Dang DD; Department of Neurosurgery, Inova Fairfax Hospital, Falls Church, Virginia, United States., Gong AD; Department of Neurosurgery, Inova Fairfax Hospital, Falls Church, Virginia, United States., Dang JV; Department of Internal Medicine, Walter Reed Military Medical Center, Bethesda, Maryland, United States., Mugge LA; Department of Neurosurgery, Inova Fairfax Hospital, Falls Church, Virginia, United States., Mansinghani S; Department of Neurosurgery, Inova Fairfax Hospital, Falls Church, Virginia, United States., Ziu M; Department of Neurosurgery, Inova Fairfax Hospital, Falls Church, Virginia, United States., Cohen AL; Department of Neuro-Oncology, Inova Schar Cancer Institute, Inova Health System, Fairfax, Falls Church, Virginia, United States., Vyas N; Department of Neurosurgery, Inova Fairfax Hospital, Falls Church, Virginia, United States.
المصدر: Journal of neurological surgery reports [J Neurol Surg Rep] 2023 Oct 16; Vol. 84 (4), pp. e129-e139. Date of Electronic Publication: 2023 Oct 16 (Print Publication: 2023).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Thieme Country of Publication: Germany NLM ID: 101601540 Publication Model: eCollection Cited Medium: Print ISSN: 2193-6358 (Print) Linking ISSN: 21936358 NLM ISO Abbreviation: J Neurol Surg Rep Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Stuttgart : Thieme
مستخلص: Background  Despite advances in multimodal oncologic therapies and molecular genetics, overall survival (OS) in patients with high-grade astrocytomas remains poor. We present an illustrative case and systematic review of rare, predominantly extra-axial World Health Organization (WHO) grade 4 astrocytomas located within the cerebellopontine angle (CPA) and explore the impact of anatomic location on diagnosis, management, and outcomes. Methods  A systematic review of adult patients with predominantly extra-axial WHO grade 4 CPA astrocytomas was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines through December 2022. Results  Eighteen articles were included comprising 21 astrocytomas: 13 exophytic tumors arising from the cerebellopontine parenchyma and 8 tumors originating from a cranial nerve root entry zone. The median OS was 15 months with one-third of cases demonstrating delayed diagnosis. Gross total resection, molecular genetic profiling, and use of ancillary treatment were low. We report the only patient with an integrated isocitrate dehydrogenase 1 (IDH-1) mutant diagnosis, who, after subtotal resection and chemoradiation, remains alive at 40 months without progression. Conclusion  The deep conical-shaped corridor and abundance of eloquent tissue of the CPA significantly limits both surgical resection and utility of device-based therapies in this region. Prompt diagnosis, molecular characterization, and systemic therapeutic advances serve as the predominant means to optimize survival for patients with rare skull base astrocytomas.
Competing Interests: Conflict of Interest None declared.
(The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).)
References: Front Neurol. 2018 Jan 15;8:748. (PMID: 29379468)
J Neurooncol. 2020 Jun;148(2):221-229. (PMID: 32385699)
J Neurosurg. 2018 Dec 21;131(6):1835-1839. (PMID: 30579279)
Brain Tumor Res Treat. 2018 Oct;6(2):78-81. (PMID: 30381921)
J Neurol Surg Rep. 2014 Aug;75(1):e67-72. (PMID: 25083393)
Br J Cancer. 2020 May;122(11):1580-1589. (PMID: 32291392)
Neurooncol Adv. 2021 Mar 26;3(1):vdab047. (PMID: 34131646)
J Clin Neurosci. 2020 Feb;72:328-334. (PMID: 31864830)
Asian J Neurosurg. 2017 Jan-Mar;12(1):62-64. (PMID: 28413536)
J Neurosurg. 2020 Oct 9;:1-10. (PMID: 33035996)
Curr Oncol Rep. 2020 Mar 6;22(4):32. (PMID: 32140793)
Int J Part Ther. 2018 Spring;4(4):28-36. (PMID: 31773013)
World Neurosurg. 2019 Feb;122:48-52. (PMID: 30347301)
Radiat Oncol. 2021 Dec 20;16(1):240. (PMID: 34930368)
Neurosurg Focus. 2018 Feb;44(2):E16. (PMID: 29385923)
Sci Rep. 2020 Jul 15;10(1):11622. (PMID: 32669604)
J Neurooncol. 2020 Mar;147(1):125-133. (PMID: 31989489)
BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
J Neurooncol. 2022 Jun;158(2):225-253. (PMID: 35195819)
Clin Neurol Neurosurg. 2020 Aug;195:105942. (PMID: 32470780)
J Neurosurg. 2011 May;114(5):1288-93. (PMID: 21250796)
J Neurooncol. 2022 Jun;158(2):167-177. (PMID: 35246769)
N Engl J Med. 2005 Mar 10;352(10):997-1003. (PMID: 15758010)
Neuro Oncol. 2022 Nov 2;24(Suppl 6):S16-S24. (PMID: 36322100)
World Neurosurg. 2016 Aug;92:580.e17-580.e21. (PMID: 27338213)
Radiat Oncol. 2023 Feb 23;18(1):38. (PMID: 36823671)
Acta Neurochir (Wien). 2020 Nov;162(11):2595-2617. (PMID: 32728903)
Neurosurg Clin N Am. 2021 Jan;32(1):117-128. (PMID: 33223020)
Brain Tumor Res Treat. 2017 Apr;5(1):1-9. (PMID: 28516072)
AJNR Am J Neuroradiol. 2015 Jul;36(7):1349-54. (PMID: 25857757)
J Korean Neurosurg Soc. 2017 May;60(3):380-384. (PMID: 28490168)
Clin Oncol (R Coll Radiol). 2017 Jan;29(1):15-25. (PMID: 27743773)
J Clin Diagn Res. 2014 Apr;8(4):QD01-3. (PMID: 24959488)
Am J Surg Pathol. 2021 Aug 1;45(8):1082-1090. (PMID: 33606385)
J Neurosurg Sci. 1997 Dec;41(4):409-11. (PMID: 9555650)
Front Oncol. 2019 Sep 26;9:963. (PMID: 31616641)
Acta Neuropathol. 2020 Oct;140(4):569-581. (PMID: 32776277)
Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):443-451. (PMID: 29066124)
Curr Oncol. 2015 Aug;22(4):e273-81. (PMID: 26300678)
Br J Neurosurg. 2012 Feb;26(1):96-8. (PMID: 21707322)
Pract Radiat Oncol. 2016 Jul-Aug;6(4):217-225. (PMID: 27211230)
Front Oncol. 2021 May 26;11:666734. (PMID: 34123831)
J Neurooncol. 2020 Nov;150(2):215-267. (PMID: 33215344)
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. (PMID: 34185076)
Neurol Med Chir (Tokyo). 1997 May;37(5):411-5. (PMID: 9184441)
J Pak Med Assoc. 2020 May;70(5):939-941. (PMID: 32400760)
J Neurosurg. 2015 Jan;122(1):78-81. (PMID: 25380115)
Rep Pract Oncol Radiother. 2021 Dec 30;26(6):1045-1050. (PMID: 34992879)
JAMA. 2017 Dec 19;318(23):2306-2316. (PMID: 29260225)
J Appl Clin Med Phys. 2012 Jul 05;13(4):3826. (PMID: 22766954)
N Engl J Med. 2009 Feb 19;360(8):765-73. (PMID: 19228619)
Radiat Oncol. 2020 Jun 8;15(1):145. (PMID: 32513205)
Clin Neuropathol. 2013 Jan-Feb;32(1):58-65. (PMID: 22943956)
J Ther Ultrasound. 2016 Jan 22;4:2. (PMID: 26807257)
Surg Neurol Int. 2021 May 17;12:228. (PMID: 34221559)
J Neurol Surg B Skull Base. 2021 Feb;82(Suppl 1):S29-S30. (PMID: 33717809)
Front Neurol. 2020 Sep 17;11:1036. (PMID: 33041980)
N Engl J Med. 2005 Mar 10;352(10):987-96. (PMID: 15758009)
JAMA Oncol. 2020 Apr 1;6(4):495-503. (PMID: 32027343)
فهرسة مساهمة: Keywords: WHO grade 4 astrocytoma; brainstem glioma; cerebellopontine angle; glioblastoma; high-grade glioma; lateral skull base
تواريخ الأحداث: Date Created: 20231019 Latest Revision: 20231020
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC10580070
DOI: 10.1055/a-2172-7770
PMID: 37854309
قاعدة البيانات: MEDLINE
الوصف
تدمد:2193-6358
DOI:10.1055/a-2172-7770